Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Iobenguane I-131 in Treating Patients with Recurrent or Refractory Neuroblastoma or Non-neuroblastic Iobenguane Avid Tumors

Trial Status: temporarily closed to accrual and intervention

This phase II trial studies how well iobenguane I-131 works in treating patients with neuroblastoma or non-neuroblastic iobenguane avid tumors that has come back after a period of improvement or that does not respond to treatment. Iobenguane I-131 may help deliver radiation to the tumor cells and cause them to die.